N末端B型利钠肽原与普通人群亚临床脑损伤的关系
基于鹿特丹研究的前瞻性人群队列,对2397名无痴呆、无卒中且无临床心脏疾病诊断的中年及老年人测量血清NT-proBNP并行1.5T MR检查。结果显示,NT-proBNP水平升高与全脑体积减小(以灰质为主)、白质病变体积增大及正常表现白质微结构改变相关。
要点
- NT-proBNP每升高1个标准差,全脑体积z评分平均降低0.021,主要由灰质体积降低驱动。
- NT-proBNP每升高1个标准差,白质病变体积z评分平均增加0.090。
- NT-proBNP每升高1个标准差,正常表现白质FA降低0.048、MD升高0.054。
核心结论
- 在社区居住人群中,较高的血清NT-proBNP水平与亚临床脑损伤的容积和微结构MR影像标志物相关。
研究设计与样本
- 前瞻性人群队列研究,纳入2397名无痴呆、无卒中且无临床心脏疾病诊断的参与者(平均年龄56.6岁,范围45.7-87.3岁),来自鹿特丹研究,均行1.5T MR检查。
关键影像表现/征象
- NT-proBNP水平较高与全脑体积较小相关,且主要由灰质体积减小驱动。
- NT-proBNP水平较高与白质病变体积较大相关。
- NT-proBNP水平较高与正常表现白质FA较低及MD较高相关。
诊断标准与关键数值
- NT-proBNP每升高1个标准差,全脑体积z评分平均差为-0.021(95%CI:-0.034,-0.007;P=0.003)。
- NT-proBNP每升高1个标准差,灰质体积z评分平均差为-0.037(95%CI:-0.057,-0.017;P<0.001)。
- NT-proBNP每升高1个标准差,白质病变体积z评分平均差为0.090(95%CI:0.051,0.129;P<0.001)。
- NT-proBNP每升高1个标准差,正常表现白质FA z评分平均差为-0.048(95%CI:-0.088,-0.008;P=0.019)。
- NT-proBNP每升高1个标准差,正常表现白质MD z评分平均差为0.054(95%CI:0.018,0.091;P=0.004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Purpose To investigate the association between N-terminal pro-B-type natriuretic peptide (NT-proBNP), which is a marker of heart disease, and markers of subclinical brain damage on magnetic resonance (MR) images in community-dwelling middle-aged and elderly subjects without dementia and without a clinical diagnosis of heart disease. Materials and Methods This prospective population-based cohort study was approved by a medical ethics committee overseen by the national government, and all participants gave written informed consent. Serum levels of NT-proBNP were measured in 2397 participants without dementia or stroke (mean age, 56.6 years; age range, 45.7-87.3 years) and without clinical diagnosis of heart disease who were drawn from the population-based Rotterdam Study. All participants were examined with a 1.5-T MR imager. Multivariable linear and logistic regression analyses were used to investigate the association between NT-proBNP level and MR imaging markers of subclinical brain damage, including volumetric, focal, and microstructural markers. Results A higher NT-proBNP level was associated with smaller total brain volume (mean difference in z score per standard deviation increase in NT-proBNP level, -0.021; 95% confidence interval [CI]: -0.034, -0.007; P = .003) and was predominantly driven by gray matter volume (mean difference in z score per standard deviation increase in NT-proBNP level, -0.037; 95% CI: -0.057, -0.017; P < .001). Higher NT-proBNP level was associated with larger white matter lesion volume (mean difference in z score per standard deviation increase in NT-proBNP level, 0.090; 95% CI: 0.051, 0.129; P < .001), with lower fractional anisotropy (mean difference in z score per standard deviation increase in NT-proBNP level, -0.048; 95% CI: -0.088, -0.008; P = .019) and higher mean diffusivity (mean difference in z score per standard deviation increase in NT-proBNP level, 0.054; 95% CI: 0.018, 0.091; P = .004) of normal-appearing white matter. Conclusion In community-dwelling persons, higher serum NT-proBNP levels are associated with volumetric and microstructural MR imaging markers of subclinical brain damage. © RSNA, 2016 Online supplemental material is available for this article.
引用
- Zonneveld HI, Ikram MA, Hofman A, et al. N-Terminal Pro-B-Type Natriuretic Peptide and Subclinical Brain Damage in the General Population. Radiology. 2016. PMID: 27924720. doi:10.1148/radiol.2016160548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。